Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.
Pillai V, Muralidharan K, Meng W, Bagashev A, Oldridge DA, Rosenthal J, Van Arnam J, Melenhorst JJ, Mohan D, DiNofia AM, Luo M, Cherian S, Fromm JR, Wertheim G, Thomas-Tikhonenko A, Paessler M, June CH, Luning Prak ET, Bhoj VG, Grupp SA, Maude SL, Rheingold SR. Pillai V, et al. Among authors: muralidharan k. Blood Adv. 2019 Nov 26;3(22):3539-3549. doi: 10.1182/bloodadvances.2019000692. Blood Adv. 2019. PMID: 31738832 Free PMC article.
RhoA Allosterically Activates Phospholipase Cε via its EF Hands.
Ohri V, Samassekou K, Muralidharan K, Garland-Kuntz EE, Fisher IJ, Hogan WC, Davis BM, Lyon AM. Ohri V, et al. Among authors: muralidharan k. bioRxiv [Preprint]. 2024 Nov 14:2024.11.14.623250. doi: 10.1101/2024.11.14.623250. bioRxiv. 2024. PMID: 39605621 Free PMC article. Preprint.
Evidence for an HPV one-dose schedule.
Stanley M, Schuind A, Muralidharan KK, Guillaume D, Willens V, Borda H, Jurgensmeyer M, Limaye R. Stanley M, et al. Among authors: muralidharan kk. Vaccine. 2024 Jul 11;42 Suppl 2:S16-S21. doi: 10.1016/j.vaccine.2024.01.046. Epub 2024 Nov 7. Vaccine. 2024. PMID: 39521566 Free article. Review.
Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease.
Toda Y, Iwatsubo T, Nakamura Y, Matsuda N, Miyata M, Jin M, Chen T, Kuribayashi K, Tian Y, Hughes R, Yamamoto J, Muralidharan KK, Rubel C, Hutchison RM, Budd Haeberlein S. Toda Y, et al. Among authors: muralidharan kk. J Prev Alzheimers Dis. 2024;11(5):1260-1269. doi: 10.14283/jpad.2024.106. J Prev Alzheimers Dis. 2024. PMID: 39350371 Free PMC article. Clinical Trial.
228 results